CLINICAL_TRIALS
withdrawal
· 2026-01-26
Clinical Trial Update: Magnesphere for Autonomic Alteration [NA]
Summary
The University of Oklahoma-sponsored clinical trial evaluating Magnesphere for autonomic alteration in heart failure with reduced ejection fraction has been wit…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University of Oklahoma | Conditions: Hart Failure With Reduced Ejection Fraction | NA | Status: WITHDRAWN